Work

Supplementary Data 1 from A Phase 1/2 Multicenter Randomized Trial of Local Ablation plus Toripalimab versus Toripalimab Alone for Previously Treated Unresectable Hepatocellular Carcinoma

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Method, Table 1-9

DOI: 10.1158/1078-0432.23814567

Authors: Chunhui Zhou, Yan Li, Jiaping Li, Botian Song, Hanfeng Li, Bin Liang, Shanzhi Gu, Haiping Li, Changyong Chen, Sai Li, Changli Peng, Fei Liu, Juxiong Xiao, Xueying Long, Ping Li, Zhengping Xiong, Xiaoping Yi, Weihua Liao, Liangrong Shi

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4385457652

Cites:

Cited by:

Related to: 10